New psoriasis pill shows promise in early trial
Symptom relief
Terminated
This study tests whether a daily pill called IRX4204 can safely improve mild to moderate plaque psoriasis in adults. Twenty participants will take the drug or a placebo for 28 days and have weekly checkups. The goal is to see if the drug clears or nearly clears skin plaques and i…
Phase: PHASE2 • Sponsor: Io Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC